Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated May 30, 2025, titled "Completion of Acquisition of Checkpoint Therapeutics".
Press Release May 30 2025
Filed with NSE ·
6ix hasn’t read this filing yet.
Sun Pharmaceutical Industries Limited on 6ix
Earlier from Sun Pharmaceutical Industries
- Press Release May 16 2025
- Press Release May 12 2025
- Press Release May 08 2025
- Sun Pharma and Moebius Medical Announce Dual Publications on MM-II's Phase 2b Clinical Trial Results and Mechanism of Action in Osteoarthritis and Cartilage
- Press Release Apr 24 2025
Later from Sun Pharmaceutical Industries
- Press Release Jun 03 2025
- Pharmazz Inc. Secures $25 Million Strategic Equity Investment from Sun Pharmaceutical Industries Ltd.
- Sun Pharma appoints Kirti Ganorkar as the Managing Director, Dilip Shanghvi to continue as the Executive Chairman of the Board
- Press Release Jun 24 2025
- Sun Pharma Announces Appointment of Richard Ascroft as CEO North America
Follow Sun Pharmaceutical Industries into a list and get an email when it puts out news.
Follow Sun Pharmaceutical Industries